BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy
Bouchalova, Katerina, Svoboda, Marek, Kharaishvili, Gvantsa, Vrbkova, Jana, Bouchal, Jan, Trojanec, Radek, Koudelakova, Vladimira, Radova, Lenka, Cwiertka, Karel, Hajduch, Marian, Kolar, ZdenekVolume:
36
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-015-3061-7
Date:
June, 2015
File:
PDF, 537 KB
english, 2015